CHARACTERIZATION OF DYSKINESIAS INDUCED BY L-DOPA IN MPTP-TREATED SQUIRREL-MONKEYS

被引:51
作者
BOYCE, S
RUPNIAK, NMJ
STEVENTON, MJ
IVERSEN, SD
机构
[1] Merck Sharp and Dohme Research Laboratories, Neuroscience Research Centre, Harlow, CM20 2QR, Essex, Terlings Park
关键词
Chorea; Dystonia; l-dopa; Parkinson's disease; Squirrel monkey;
D O I
10.1007/BF02245739
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Intermittent treatment with l-dopa over a 2-year period induced abnormal involuntary movements in MPTP-treated squirrel monkeys. Dyskinesias included a choreic and dystonic component. Dose-response curves for chorea and dystonia revealed that the same dose of l-dopa (30 mg/kg) induced the highest score for both dyskinesias; however, the severity was much greater for chorea. Choreic movements were always most prevalent at the time of peak effect, whereas dystonia was apparent at the time of peak effect and at "end-of-dose", and was occasionally observed spontaneously. Our findings indicate that squirrel monkeys treated with MPTP develop l-dopa-induced dyskinesias which closely resemble those observed in Parkinson's disease. This species provides a valuable animal model to develop improved therapeutic agents. © 1990 Springer-Verlag.
引用
收藏
页码:21 / 27
页数:7
相关论文
共 38 条
[1]  
[Anonymous], 1982, MOVEMENT DISORD
[2]  
BARBEAU A, 1975, LANCET, V1, P756
[3]   CHRONIC TREATMENT WITH L-DOPA, BUT NOT BROMOCRIPTINE INDUCES DYSKINESIA IN MPTP-PARKINSONIAN MONKEYS - CORRELATION WITH [H-3] SPIPERONE BINDING [J].
BEDARD, PJ ;
DIPAOLO, T ;
FALARDEAU, P ;
BOUCHER, R .
BRAIN RESEARCH, 1986, 379 (02) :294-299
[4]   LEVODOPA-INDUCED DYSKINESIA AND RESPONSE FLUCTUATIONS IN PRIMATES RENDERED PARKINSONIAN WITH 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE (MPTP) [J].
CLARKE, CE ;
SAMBROOK, MA ;
MITCHELL, IJ ;
CROSSMAN, AR .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1987, 78 (03) :273-280
[5]  
COOPER IS, 1970, L DOPA PARKINSONISM, P170
[6]   APOMORPHINE HYDROCHLORIDE-INDUCED IMPROVEMENT IN HUNTINGTONS-CHOREA - STIMULATION OF DOPAMINE RECEPTOR [J].
CORSINI, GU ;
ONALI, P ;
MASALA, C ;
CIANCHETTI, C ;
MANGONI, A ;
GESSA, G .
ARCHIVES OF NEUROLOGY, 1978, 35 (01) :27-30
[7]  
CRISWELL H, 1989, J NEUROSCI, V9, P125
[8]   MPTP-INDUCED PARKINSONISM IN THE MONKEY - NEUROCHEMICAL PATHOLOGY, COMPLICATIONS OF TREATMENT AND PATHOPHYSIOLOGICAL MECHANISMS [J].
CROSSMAN, AR ;
CLARKE, CE ;
BOYCE, S ;
ROBERTSON, RG ;
SAMBROOK, MA .
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1987, 14 (03) :428-435
[9]   INJECTED APOMORPHINE AND ORALLY ADMINISTERED LEVODOPA IN PARKINSONISM [J].
DUBY, SE ;
PAPAVASILIOU, PS ;
COTZIAS, GC ;
LAWRENCE, WH .
ARCHIVES OF NEUROLOGY, 1972, 27 (06) :474-+
[10]   BEHAVIORAL AND BIOCHEMICAL EFFECT OF CHRONIC TREATMENT WITH D-1 AND OR D-2 DOPAMINE AGONISTS IN MPTP MONKEYS [J].
FALARDEAU, P ;
BOUCHARD, S ;
BEDARD, PJ ;
BOUCHER, R ;
DIPAOLO, T .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 150 (1-2) :59-66